Sam James

Sam James is an experienced professional in the pharmaceutical and biotechnology sectors, currently serving as Director of Patient Access & Community Engagement at Sobi - Swedish Orphan Biovitrum AB since June 2021. Prior roles include Director of Regional Market Access at Arvelle Therapeutics and Director, Head of External Affairs at Takeda, focusing on public policy, communications, and patient advocacy. A long tenure at Shire saw Sam hold multiple leadership positions, such as Director, Head of Access & External Affairs for the UK and Ireland. Earlier career experience included various sales, marketing, and medical roles at Ferring Pharmaceuticals. Sam holds a BSc in Biology from Brunel University of London and a degree in Health Economics from the University of Aberdeen.